Biopharma Update on the Novel Coronavirus: July 10

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 10, 2020. Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges US market, EU, Canada, and other regulated […]

Atox Bio Announces a Positive Effect of Reltecimod on Resolution of Organ Dysfunction in Phase 3 ACCUTE Trial for Patients with Necrotizing Soft Tissue Infection (“Flesh Eating Disease”)

Atox Bio announced results from the randomized, double-blind, placebo-controlled Phase 3 ACCUTE trial of reltecimod for the early treatment of severe Necrotizing Soft Tissue Infection. Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory information, […]

BioSpace Global Roundup, July 9

Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses. Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges US market, EU, Canada, and other regulated […]

Low-Dose Radiation May Lower Inflammation in COVID-19 Patients

Low-dose radiation therapy seems to improve outcomes for COVID-19 patients. At least a dozen clinical trials are underway throughout the world to further explore the benefits. Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory […]